Growth Metrics

Harvard Bioscience (HBIO) Long-Term Deferred Tax (2016 - 2019)

Historic Long-Term Deferred Tax for Harvard Bioscience (HBIO) over the last 11 years, with Q2 2019 value amounting to $210000.0.

  • Harvard Bioscience's Long-Term Deferred Tax rose 1864.41% to $210000.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $210000.0, marking a year-over-year increase of 1864.41%. This contributed to the annual value of $182000.0 for FY2017, which is 10346.01% up from last year.
  • Per Harvard Bioscience's latest filing, its Long-Term Deferred Tax stood at $210000.0 for Q2 2019, which was up 1864.41% from $208000.0 recorded in Q1 2019.
  • Over the past 5 years, Harvard Bioscience's Long-Term Deferred Tax peaked at $11.0 million during Q3 2015, and registered a low of -$5.3 million during Q4 2016.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $954000.0 (2016), whereas its average is $1.8 million.
  • As far as peak fluctuations go, Harvard Bioscience's Long-Term Deferred Tax tumbled by 12494.62% in 2015, and later skyrocketed by 10346.01% in 2017.
  • Over the past 5 years, Harvard Bioscience's Long-Term Deferred Tax (Quarter) stood at -$5.0 million in 2015, then dropped by 5.54% to -$5.3 million in 2016, then soared by 103.46% to $182000.0 in 2017, then dropped by 1.65% to $179000.0 in 2018, then increased by 17.32% to $210000.0 in 2019.
  • Its Long-Term Deferred Tax stands at $210000.0 for Q2 2019, versus $208000.0 for Q1 2019 and $179000.0 for Q3 2018.